Net Loss of Astec Lifesciences reported to Rs 40.38 crore in the quarter ended December 2024 as against net loss of Rs 24.33 crore during the previous quarter ended December 2023. Sales rose 84.80% to Rs 93.86 crore in the quarter ended December 2024 as against Rs 50.79 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 93.86 | 50.79 | 85 |
| OPM % | -6.12 | -36.09 | - |
| PBDT | -13.75 | -23.52 | 42 |
| PBT | -25.15 | -32.22 | 22 |
| NP | -40.38 | -24.33 | -66 |